Denali Therapeutics DNLI
NASDAQ DNLI
$20.00 -0.53 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Cash from Investing Activities (2017 - 2026)

Updated

Denali Therapeutics' Cash from Investing Activities came in at -$104.08 million for Q2 2026, compared with $157.94 million a year earlier.

Analysis

Denali Therapeutics (DNLI) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Denali Therapeutics reported Cash from Investing Activities of $68.98 million, down 84.4% year-over-year; for FY2025, it came in at $255.28 million.

  • Going back by year, Cash from Investing Activities was -$88.76 million in FY2024, $249.31 million in FY2023, -$141.39 million in FY2022 and -$21.63 million in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Cash from Investing Activities since Q1 2024.
  • Year-over-year, Cash from Investing Activities increased in three of the last six quarters, with growth averaging 77.7%.
  • The fastest year-over-year change in Cash from Investing Activities over five years came in Q3 2023 (growth of 554.4%), and the weakest in Q4 2025 (a decline of 87.9%).
  • Business Quant data shows DNLI's Cash from Investing Activities at $94.46 million (Q1 2026), $20.77 million (Q4 2025) and $57.83 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Denali Therapeutics 3.20 Bn 3.20 Bn 3.51 Mn -104.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -104.08 Mn
Mar 31, 2026 94.46 Mn
Dec 31, 2025 20.77 Mn
Sep 30, 2025 57.83 Mn
Jun 30, 2025 157.94 Mn
Mar 31, 2025 18.75 Mn
Dec 31, 2024 172.21 Mn
Sep 30, 2024 93.66 Mn
Jun 30, 2024 98.57 Mn
Mar 31, 2024 -453.19 Mn
Dec 31, 2023 73.05 Mn
Sep 30, 2023 100.91 Mn
Jun 30, 2023 168.07 Mn
Mar 31, 2023 -92.72 Mn
Dec 31, 2022 -127.56 Mn
Sep 30, 2022 15.42 Mn
Jun 30, 2022 88.63 Mn
Mar 31, 2022 -117.88 Mn
Dec 31, 2021 -40.75 Mn
Sep 30, 2021 -53.01 Mn
API Access

Denali Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=DNLI&period=max&api_key=YOUR_API_KEY